U.S. stock-market indexes ended a turbulent session slightly lower on Wednesday after the Federal Reserve delivered its sixth interest-rate increase since the end of 2015 and signaled it still expects to deliver two more before the end of the year.
The central bank also upped its forecast for the number of rate increases it expects to deliver in 2019. Stocks saw whipsaw price action, swinging....More>>>
The business model that felled what was once the world’s biggest renewable energy company is alive and making money in Britain.
Listed funds using the yieldco model are outperforming the FTSE All-Share Index on a risk-adjusted return basis, according to research from Imperial College.
“Yieldco” had almost become a dirty word after SunEdison Inc.’s bankruptcy....More>>>
Diplomat Pharmacy (NYSE: DPLO) and Rite Aid (NYSE:RAD) are both small-cap retail/wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.
Insider and Institutional Ownership
Get Diplomat Pharmacy alerts:....More>>>
As earnings season kicked into gear, Netflix stole the show this week, posting surging revenue and smashing its own guidance for subscriber growth. The optimistic report from management on Netflix’s business sent shares 10% higher.
Next week will feature a range of earnings reports. But the most interesting will be the following stocks. Ahead of their earnings....More>>>
Netflix (NASDAQ:NFLX) has been a stunning performer in the streaming video era. Since that fateful Qwikster episode in 2011, share prices have soared 3,370% higher. It’s money-making drama of the highest caliber.
But past performance is no guarantee of future returns. There must surely be a few stocks on the market today that will crush Netflix’s returns from this....More>>>
Motley Fool co-founder David Gardner regularly recommends sets of stocks on the Rule Breaker Investing podcast — essentially giving us all a free taste of the choices he and his team make in Motley Fool Supernova’s portfolio universe. And this week, he gives us his 14th batch of five.
Now, Gardner has thus far managed something pretty remarkable: For every five-stock....More>>>
As we work to instill good values in our children, we generally try to discourage boasting. But as long-term investors with the world’s most powerful tool for wealth creation — the stock market — at our fingertips, we’ll readily admit we want to buy and hold stocks that our kids will at least be tempted to brag about someday.
To that end, three top Motley Fool investors....More>>>
When will the world see its first trillionaire? A British charity estimates that it could happen within 25 years and that it will be none other than Microsoft founder Bill Gates.
Oxfam, the U.K. world hunger organization, meant to shame the world’s richest with its list of multi-billionaires. Which is odd, considering that Gates is a founder, with Warren Buffett, of The Giving Pledge....More>>>
In the stock market, I have a couple rules I like to follow. One of them is to almost always stay away from stocks trading under $5. After all, there is a reason they are under $5, and its not because things are going well. But every once in a while, one finds a hidden gem among these cheap stocks. I think Rite Aid Corporation (NYSE:RAD) is one of those hidden gems.
Rite Aid Corp. (NYSE: RAD) is finding itself in an odd situation. After a failed merger that crushed its stock, Rite Aid may never be able to get back to its highs of recent years, now that it has been shrinking its footprint. Or is that view false?
The news flow around Rite Aid showed that the retail pharmacy completed the pilot closing, and first subsequent closings under the amended and....More>>>